Stay updated on TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.

Latest updates to the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page
- Check5 days agoChange DetectedAdded a new site revision tag (Revision: v3.4.2) and removed the older government funding notice; the core study details and page content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoChange DetectedNotable updates include a government funding notice at the top of the page and a new Nat Med citation for autologous multiantigen-targeted T cell therapy in pancreatic cancer, with the previous Nat Med citation removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check19 days agoChange DetectedNon-significant updates include UI/metadata changes: the page now shows a glossary toggle, new Last Update fields (Submitted that Met QC Criteria and Last Update Posted), a No FEAR Act Data notice, and a Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check33 days agoChange DetectedRevision v3.3.4 was added and Revision v3.3.3 was removed. This is a minor, non-content-changing update to the page’s versioning.SummaryDifference0.1%

- Check40 days agoChange DetectedNew Publications entry added for the Nat Med 2026 paper by Musher et al. under Publications; this update does not affect core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedAdded a Locations section with Texas as a site and updated the page revision to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to TAA-Specific CTLs in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAA-Specific CTLs in Pancreatic Cancer Clinical Trial page.